Literature DB >> 8452593

Interictal and postictal focal hypermetabolism on positron emission tomography.

H T Chugani1, D A Shewmon, S Khanna, M E Phelps.   

Abstract

Decreased glucose utilization in the epileptogenic zone is typically observed interictally on positron emission tomography (PET), whereas ictal PET studies reveal complex patterns of increased and decreased metabolism. PET findings of 7 children, ages 2 months to 16 years, are described and demonstrate small focal regions of hypermetabolism in the absence of clinical or electrographic seizure during the 2-deoxy-2[18F]fluoro-D-glucose (FDG) uptake period. Magnetic resonance imaging scans were nonlocalizing in 5 of 7 children. In 4 children, seizures had not occurred for at least several hours prior to PET. Electroencephalography during PET disclosed active spike-and-wave activity on the side of interictal hypermetabolism in these 4 children. The remaining 3 children had seizures within 15 min prior to FDG injection and were considered postictal; their PET images revealed focal hypermetabolism. Results indicated the need for electroencephalographic monitoring during functional neuroimaging studies of all epileptic patients. The biochemical basis of interictal hypermetabolism is probably related to increased energy consumption by an active epileptogenic focus, whereas postictal hypermetabolism is likely due to energy expenditure for the restoration of resting membrane potentials and chemical homeostasis following an epileptic event.

Entities:  

Mesh:

Year:  1993        PMID: 8452593     DOI: 10.1016/0887-8994(93)90003-u

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  14 in total

Review 1.  Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy.

Authors:  Sandeep Sood; Harry T Chugani
Journal:  Childs Nerv Syst       Date:  2006-06-24       Impact factor: 1.475

2.  Metabolic Correlates of the Ictal-Interictal Continuum: FDG-PET During Continuous EEG.

Authors:  Aaron F Struck; M Brandon Westover; Lance T Hall; Gina M Deck; Andrew J Cole; Eric S Rosenthal
Journal:  Neurocrit Care       Date:  2016-06       Impact factor: 3.210

3.  SPECT and epilepsy with continuous spike waves during slow-wave sleep.

Authors:  R Gaggero; M Caputo; P Fiorio; A Pessagno; M G Baglietto; P Muttini; M De Negri
Journal:  Childs Nerv Syst       Date:  1995-03       Impact factor: 1.475

Review 4.  How to establish causality in epilepsy surgery.

Authors:  Eishi Asano; Erik C Brown; Csaba Juhász
Journal:  Brain Dev       Date:  2013-05-15       Impact factor: 1.961

5.  Cortical glucose metabolism correlates negatively with delta-slowing and spike-frequency in epilepsy associated with tuberous sclerosis.

Authors:  Masaaki Nishida; Eishi Asano; Csaba Juhász; Otto Muzik; Sandeep Sood; Harry T Chugani
Journal:  Hum Brain Mapp       Date:  2008-11       Impact factor: 5.038

6.  Cortical glucose metabolism positively correlates with gamma-oscillations in nonlesional focal epilepsy.

Authors:  Masaaki Nishida; Csaba Juhász; Sandeep Sood; Harry T Chugani; Eishi Asano
Journal:  Neuroimage       Date:  2008-07-03       Impact factor: 6.556

7.  Increased interictal cerebral glucose metabolism in a cortical-subcortical network in drug naive patients with cryptogenic temporal lobe epilepsy.

Authors:  M Franceschi; G Lucignani; A Del Sole; C Grana; S Bressi; F Minicucci; C Messa; M P Canevini; F Fazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

Review 8.  PET studies in epilepsy.

Authors:  Ismet Sarikaya
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

9.  Quantitative analysis of simultaneous EEG features during PET studies for childhood partial epilepsy.

Authors:  Yun Jung Hur; Joon Soo Lee; Jong Doo Lee; Mi Jin Yun; Heung Dong Kim
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

10.  Determining surgical candidacy in temporal lobe epilepsy.

Authors:  Alireza Mansouri; Aria Fallah; Taufik A Valiante
Journal:  Epilepsy Res Treat       Date:  2012-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.